A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
Recursion CEO: Publicly funded research built the biopharma industry. Now it needs our help
America is the global leader in health care innovation. We lead in medical research and in rapidly developing treatments for emerging health care priorities. That